Results 21 to 30 of about 887,639 (384)

Vomiting

open access: yesThe Korean Journal of Gastroenterology, 2017
Many disorders can cause either acute or chronic vomiting. However, in most cases, vomiting is self-limited. A correct diagnosis is possible by conducting careful histories and physical examinations. In cases of severe vomiting, further testing, including laboratory studies, radiological images, endoscopic evaluation, and gastrointestinal motility ...
Ga Hee Kim, Kee Wook Jung
openaire   +3 more sources

Clinical signs, duodenal histopathological grades, and serum high‐mobility group box 1 concentrations in dogs with inflammatory bowel disease

open access: yesJournal of Veterinary Internal Medicine, 2021
Background Inflammatory bowel disease (IBD) commonly occurs in dogs, but there is lack of information about potential biomarkers of clinical and histopathologic severity.
Jong‐Hwan Lee   +9 more
doaj   +1 more source

Ondansetron Compared with Doxylamine and Pyridoxine for Treatment of Nausea and Vomiting in Pregnancy [PDF]

open access: yesInternational Journal of Medical Arts, 2020
Background: Nausea and vomiting affects up to 80% of the pregnant women population and are the third leading causes of maternal hospitalization during pregnancy.
Mohamed Yahia   +2 more
doaj   +1 more source

Gastrointestinal Symptoms in Children With Life-Limiting Conditions Receiving Palliative Home Care

open access: yesFrontiers in Pediatrics, 2021
Context: Children with life-limiting diseases suffer from gastrointestinal (GI) symptoms. Since the introduction of specialized palliative home care (SPHC) in Germany, it is possible to care for these children at home.
Holger Hauch   +14 more
doaj   +1 more source

On the Behavior of the Respiratory Muscles During Vomiting [PDF]

open access: yes, 1957
In order to produce vomiting in the dogs decerebrated and unanesthetized, apomorphine or copper sulfate was administered. The behaviors of both the inspiratory and the expiratory muscles were studied through the course of the act of vomiting by the ...
Hukuhara, Takesi   +2 more
core   +1 more source

Adrenal insufficiency caused by bilateral adrenal metastases - a rare treatable cause for recurrent nausea and vomiting in metastatic breast cancer [PDF]

open access: yes, 2006
Background: Nausea and vomiting are common symptoms in patients with malignant disease. Several, sometimes rare causes have to be considered to decide the right treatment.
Bausewein, Claudia   +2 more
core   +1 more source

Treatment of Nausea and Vomiting in Pregnancy: Factors Associated with ED Revisits

open access: yesWestern Journal of Emergency Medicine, 2016
Introduction: Nausea and vomiting in pregnancy (NVP) is a condition that commonly affects women in the first trimester of pregnancy. Despite frequently leading to emergency department (ED) visits, little evidence exists to characterize the nature of ED ...
Brian R. Sharp   +3 more
doaj   +1 more source

Evaluation of nausea and vomiting in pregnancy using the Pregnancy-Unique Quantification of Emesis and Nausea scale in Korea [PDF]

open access: yesObstetrics & Gynecology Science, 2018
ObjectiveSeverity of nausea and vomiting of pregnancy (NVP) is associated with adverse pregnancy outcomes and poorer quality of life (QOL). The aim of this study was to evaluate the severity of NVP and maternal well-being status using the Pregnancy ...
Hyun Joung Choi   +7 more
doaj   +1 more source

Prevalence and prognostic value of gastroenterological manifestations of COVID-19: data from the Russian University Clinic

open access: yesТерапевтический архив, 2021
Aim. Assessment of the prevalence and prognostic value of gastroenterological manifestations in patients with COVID-19. Materials and methods. A single-center retrospective cohort study was carried out.
Oleg O. Ianushevich   +21 more
doaj   +1 more source

NEPA, a new fixed combination of netupitant and palonosetron, is a cost-effective intervention for the prevention of chemotherapy-induced nausea and vomiting in the UK

open access: yesDrugs in Context, 2017
Background: The objective was to evaluate the cost-effectiveness of NEPA, an oral fixed combination netupitant (NETU, 300 mg) and palonosetron (PA, 0.5 mg) compared with aprepitant and palonosetron (APPA) or palonosetron (PA) alone, to prevent ...
Helene Cawston   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy